Yansha Sun

828 total citations
20 papers, 617 citations indexed

About

Yansha Sun is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Yansha Sun has authored 20 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Immunology and 3 papers in Surgery. Recurrent topics in Yansha Sun's work include CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (9 papers) and Colorectal Cancer Treatments and Studies (3 papers). Yansha Sun is often cited by papers focused on CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (9 papers) and Colorectal Cancer Treatments and Studies (3 papers). Yansha Sun collaborates with scholars based in China. Yansha Sun's co-authors include Zonghai Li, Bizhi Shi, Ruixin Sun, Hua Jiang, Hong Luo, Su Jingwen, Yiwei Dong, Yi Wang, Min Zhou and Guoxiu Du and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and British Journal of Pharmacology.

In The Last Decade

Yansha Sun

19 papers receiving 608 citations

Peers

Countries citing papers authored by Yansha Sun

Since Specialization

Citations

This map shows the geographic impact of Yansha Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yansha Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yansha Sun more than expected).

Fields of papers citing papers by Yansha Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yansha Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yansha Sun. The network helps show where Yansha Sun may publish in the future.

Co-authorship network of co-authors of Yansha Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yansha Sun. A scholar is included among the top collaborators of Yansha Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yansha Sun. Yansha Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial 2025 ·Nature Communications ·Rui Liu, Zhi Ji, Xia Wang, (unknown), (unknown), Lijun Ma, Jiayu Zhang, Shaohua Ge, Le Zhang, Yuchong Yang, Ning Tao, Ming Bai, Jingjing Duan, Feixue Wang, Yansha Sun, Hongli Li, (unknown), Yi Ba, Jihui Hao	5
2	The combination of anti-PD-1 antibodies, trastuzumab and chemotherapy may improve the outcome of some patients with HER2-positive alpha-fetoprotein-producing gastric cancer: a retrospective real-world analysis from a single center 2025 ·BMC Cancer ·Shaohua Ge, Feixue Wang, Hongli Li, Yuchong Yang, Le Zhang, Jingjing Duan, Ming Bai, Rui Liu, Tao Ning, Xia Wang, Zhi Ji, Yansha Sun, (unknown)	1
3	High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer 2025 ·Frontiers in Immunology ·Shuning Xu, Danyang Li, Ning Tao, (unknown), Yansha Sun, Hua Bai, (unknown), Ting Deng, Ying Liu	2
4	Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study 2024 ·Cancer Immunology Immunotherapy ·(unknown), Feixue Wang, Le Zhang, Tao Ning, Yansha Sun, Shaohua Ge, Ming Bai, Yao Lü, Hongli Li, Yi Ba	3
5	Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma 2024 ·BMC Cancer ·Yuchong Yang, (unknown), Lu Yao, (unknown), Mengqi Zhang, Ming Bai, Xia Wang, Shaohua Ge, Tao Ning, Le Zhang, Zhi Ji, Jingjing Duan, Yansha Sun, Feixue Wang, Rui Liu, Hongli Li, (unknown)	0
6	Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study 2024 ·BMC Cancer ·Jingjing Duan, (unknown), Yinghui Shi, Weixue Wang, Tongtong Wang, Tao Ning, Le Zhang, Ming Bai, Hongli Li, Rui Liu, Shaohua Ge, Xia Wang, Yuchong Yang, Zhi Ji, Feixue Wang, Yansha Sun, Yi Ba, (unknown)	3
7	GPC3-targeted CAR-T cells expressing GLUT1 or AGK exhibit enhanced antitumor activity against hepatocellular carcinoma 2024 ·Acta Pharmacologica Sinica ·Ruixin Sun, Yifan Liu, Yansha Sun, Min Zhou, Yi Wang, Bizhi Shi, Hua Jiang, Zonghai Li	17
8	Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer 2024 ·British Journal of Pharmacology ·Ruixin Sun, (unknown), Yansha Sun, (unknown), (unknown), (unknown), Bizhi Shi, Hua Jiang, Zonghai Li	8
9	CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3/NF-κB/SDF-1α axis to enhance efficacy against pancreatic cancer 2023 ·Molecular Therapy ·Ruixin Sun, Yansha Sun, Chuanlong Wu, Yifan Liu, (unknown), (unknown), Guoxiu Du, Hong Luo, Bizhi Shi, Hua Jiang, Zonghai Li	46
10	Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer 2023 ·Biochemical Pharmacology ·Ruixin Sun, (unknown), (unknown), Min Zhou, Hong Luo, Guoxiu Du, (unknown), Yansha Sun, (unknown), Su Jingwen, Mingliang Fan, Bizhi Shi, Hua Jiang, Zonghai Li	14
11	FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer 2023 ·Journal of Translational Medicine ·Yifan Liu, Yansha Sun, Peng Wang, (unknown), Yiwei Dong, Min Zhou, Bizhi Shi, Hua Jiang, Ruixin Sun, Zonghai Li	68
12	The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer 2023 ·BMC Cancer ·Yuchong Yang, Yao Lü, (unknown), Ming Bai, Xia Wang, Shaohua Ge, Tao Ning, Le Zhang, Jingjing Duan, Yansha Sun, Rui Liu, Hongli Li, Yi Ba, (unknown)	10
13	Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review 2022 ·Journal of International Medical Research ·Yansha Sun, (unknown), (unknown), Haiyan Liu, Xiaofei Zhang, Wei Wang, Kun Zhao	6
14	Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death 2022 ·Molecular Therapy ·Yi Wang, Honghong Zhang, Guoxiu Du, Hong Luo, Su Jingwen, Yansha Sun, Min Zhou, Bizhi Shi, (unknown), Hua Jiang, Zonghai Li	21
15	Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors 2022 ·Molecular Therapy — Oncolytics ·Yansha Sun, Yiwei Dong, Ruixin Sun, Yifan Liu, Yi Wang, Hong Luo, Bizhi Shi, Hua Jiang, Zonghai Li	17
16	Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion 2020 ·Clinical Cancer Research ·Hong Luo, Su Jingwen, Ruixin Sun, Yansha Sun, Yi Wang, Yiwei Dong, Bizhi Shi, Hua Jiang, Zonghai Li	129
17	Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice 2020 ·Molecular Therapy ·Ruixin Sun, Hong Luo, Su Jingwen, Shengmeng Di, Min Zhou, Bizhi Shi, Yansha Sun, Guoxiu Du, Honghong Zhang, Hua Jiang, Zonghai Li	97
18	Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells 2019 ·Frontiers in Oncology ·Hong Luo, Xiuqi Wu, Ruixin Sun, Su Jingwen, Yi Wang, Yiwei Dong, Bizhi Shi, Yansha Sun, Hua Jiang, Zonghai Li	36
19	An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment 2019 ·Frontiers in Immunology ·Yi Wang, Hua Jiang, Hong Luo, Yansha Sun, Bizhi Shi, Ruixin Sun, Zonghai Li	91
20	Antitumor efficacy of chimeric antigen receptor T cells against EGFRvIII-expressing glioblastoma in C57BL/6 mice 2019 ·Biomedicine & Pharmacotherapy ·Muhua Chen, Ruixin Sun, Bizhi Shi, Yi Wang, Shengmeng Di, Hong Luo, Yansha Sun, Zonghai Li, Min Zhou, Hua Jiang	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact